Efficacy of intravitreal triamcinolone after or concomitant with laser photocoagulation in nonproliferative diabetc retinopathy with macular edema

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 630-637

  Aydin, Erdinc ^a   Demir, Helin Deniz ^a   Yardim, Huseyin ^a   Erkorkmaz, Unal ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Clinically significant macular edema; Intravitreal triamcinolone acetonide; Macular laser photocoagulation; Nonproliferative diabetic retinopathy; Type 2 diabetes mellitus

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CLINICALLY SIGNIFICANT MACULAR EDEMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE PHOTOGRAPHY; FEMALE; HUMAN; LASER COAGULATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; AGED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; PHOTOGRAPHY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 70549092887     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900418     Document Type: Article

References (30)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets OL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: diabetic macular edema. Ophthalmology 1984; 91: 1464-74.
2. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 103: 1796-806.
3. Jonas JB, Sotker A, Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema: long term visual results. Ophthalmology 1991; 98: 1594-602.
4. Jonas JB, Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-7.
5. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic macular edema: preliminary results of a prospective controlled. Ind Ophthalmol 2004; 111: 218-25.
6. Chan CKM, Mohamed S, Shanmugam MP, Tsang C-W, Lai TYY, Lam DSC. Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol 2006; 90: 1137-41.
7. Kaderli B, Avci R, Gelisken O, Yucel AA. Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Int Ophthalmol 2005; 26: 207-14.
8. Ramezani A, Tabatabaie H, Ahmedieh H. Diabetic macular edema before and after intravitreal triamcinolone injection. Korean J Ophthalmol 2007; 21: 95-9.
9. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98: 766-85.
10. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987; 94: 761-74.
11. Yeung CK, Chan KP, Chiang SW, Pang CP, Lan DS. The toxic and stress responses of cultured human retina pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 2003; 44: 5293-300.
12. McGhee CN, Dean S, Danesh-Mayer H. Locally administrated ocular corticosteroids: benefits and risks. Drug Saf 2002; 25: 33-55.
13. Kang SW, Park CY, Ham DI. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004; 137: 313-22.
14. Bresnick GH. Diabetic macular oedema. A review. Ophthalmology 1986; 93: 989-97.
15. Tso MO, Shih CY. Experimental macular oedema after lens extraction. Invest Ophthalmol Vis Sci 1977; 16: 381-92.
16. Clover GM. Laser Photocoagulation of Retinal Disease. San Francisco, CA: Pacific Medical Press; 1988: 11-7.
17. Weiter JJ, Zuckerman R. The influence of the photoreceptor-RPE complex on the inner retina. An explanation for the beneficial effects of photocoagulation. Ophthalmology 1980; 87: 1133-9.
18. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-9.
19. Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 2002; 240: 423-9.
20. Early Treatment Diabetic Retinopathy Study Group. Treatment technique and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology 1987; 94: 761-74.
21. Bandello F, Pognuz DR, Pirracchio A, Polito A. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2004; 242: 1024-7.
22. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-7.
23. Boscia F, Furino C, Dammacco R, Ferreri P, Sborgia L, Sborgia C. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results. Eur J Ophthalmol 2005; 15: 89-95.
24. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005; 140: 695-702.
25. Jonas JB, Kreissig I, Degenring RF. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-7.
26. Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular oedema. Jpn J Ophthalmol 1995; 39: 71-6.
27. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CWG. Endophthalmitis caused by Mycobacterium chelonae abscessus After Intravitreal Injection of Triamcinolone. Arch Ophthalmol 2003; 121: 271-3.
28. Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 2003; 44: 5293-300.
29. Wallow IH. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol 1984; 102: 126-35.
30. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005; 112: 301-4.